Streetbeat News

Stock Prices

VYGR

Voyager Therapeutics (NASDAQ:VYGR) reported Q1 2024 GAAP EPS of $(0.20), surpassing the $(0.45) estimate, with sales of $19.516M also beating the $9.415M estimate. Despite these beats, both earnings and sales saw significant decreases from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 8:02 pm

CARA

Cara Therapeutics reported Q1 2024 GAAP EPS of $(0.56), missing the $(0.40) estimate, but their sales of $2.135M exceeded the $1.690M estimate. This represents a significant decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 8:02 pm

RCEL

AVITA Medical (NASDAQ:RCEL) reported Q1 EPS of $(0.73), missing the $(0.45) estimate by 62.22%, and a 97.3% decrease from last year's $(0.37) per share. However, their Q1 sales of $11.10M slightly beat the $11.05M estimate, marking a 5.25% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 8:02 pm

CVV

CVD Equipment (NASDAQ:CVV) reported a significant decrease in both earnings per share and sales for Q1, with EPS down to $(0.22) from $(0.01) YoY and sales dropping to $4.92M from $8.70M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 8:02 pm

VFS

VinFast Auto Ltd. (NASDAQ:VFS) shares surged amid a broader rally in meme stocks, driven by renewed interest from retail investors following posts by Keith Gill, a.k.a Roaring Kitty. The stock's volume exceeded 11 million shares, far above its 100-day average, partly due to interest from short-sellers. VinFast does not pay dividends but may engage in other capital allocation strategies.

Portfolio Pulse from Erica Kollmann

May 13, 2024 | 8:02 pm

FTHM

Fathom Holdings (NASDAQ:FTHM) has been analyzed by 6 analysts over the last three months, showing a shift towards more bullish ratings despite a decrease in the average 12-month price target from $6.08 to $4.33. Analysts from firms like DA Davidson, Stephens & Co., Roth MKM, and B. Riley Securities have lowered their price targets, reflecting a cautious outlook on the company's financial performance, which includes a revenue decline of -11.23% and a net margin of -11.39%. Despite these challenges, Fathom Holdings's ROE of -15.2% indicates effective use of equity capital.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 8:00 pm

AJG

Arthur J. Gallagher (NYSE:AJG) has delivered an average annual return of 11.01% over the past 20 years, turning a $100 investment into $814.27 today. With a current market capitalization of $54.81 billion, AJG's performance highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 8:00 pm

A

Over the past decade, Agilent Technologies (NYSE:A) has delivered an annualized return of 14.27%, outperforming the market by 3.51%. A $100 investment in Agilent Technologies 10 years ago would now be worth $374.92, showcasing the impact of compounded returns on investment growth. Agilent Technologies currently boasts a market capitalization of $43.19 billion.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 8:00 pm

INVH

Invitation Homes (NYSE:INVH) has been the subject of diverse analyst ratings over the past three months, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target for INVH has been raised to $37.75, reflecting a 2.72% increase from the previous target of $36.75. Analysts from firms like Keefe, Bruyette & Woods, Raymond James, and Citigroup have updated their ratings and price targets, indicating varying levels of performance expectations for the company. Invitation Homes, owning over 84,000 single-family rental homes, shows strong financial indicators such as a 3.48% revenue growth rate, a net margin of 22.0%, and an ROE of 1.4%, positioning it well in the real estate sector.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 8:00 pm

RSI

Rush Street Interactive (NYSE:RSI) has seen a diverse range of analyst ratings over the last three months, with recent updates showing a positive trend in price targets. Analysts have raised their price targets, reflecting an average increase of 19.43% from the previous average to $8.36. The company's financial performance shows a notable revenue growth of 33.92% over a three-month period, despite challenges in profitability and efficiency as indicated by its net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 8:00 pm